• CALL US : 888-529-4688
Site Logo
  • About Us
  • Dangerous Drugs
    • Invokana
    • Nexium and Prilosec
    • Risperdal
    • Talcum Powder
    • Tasigna
    • Xarelto
  • Defective Medical Devices
    • Bair Hugger
    • Breast Implants
    • Essure
    • IVC Filters
    • Physiomesh
    • Power Morcellator
  • News
  • Contact Us

Tag: Janssen Pharmaceuticals

10
Jan, 2017
Risperdal case

J&J Settles Latest Risperdal Case Before Trial

  • By
  • Andrew Steinberg
  • |
  • Current Litigation & Lawsuit News,Dangerous Prescription Drug
  • |
  • 0 Comments

On the eve of a Philadelphia Risperdal trial, Johnson & Johnson and Janssen Pharmaceuticals Inc. agreed to settle a lawsuit alleging a New York boy grew female breasts after...

Read More
04
Jan, 2017
invokana litigation

J&J and Janssen Hoping To Expand Uses For Invokana

  • By
  • Andrew Steinberg
  • |
  • Dangerous Prescription Drug,Drug & Device Manufacturers
  • |
  • 0 Comments

Healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals plan to ring in the new year with results from a seven year long study testing the effectiveness...

Read More
30
Dec, 2016
Xarelto Lawsuits

Janssen and J&J Facing Over 15,000 Xarelto Lawsuits

  • By
  • Andrew Steinberg
  • |
  • Current Litigation & Lawsuit News,Dangerous Prescription Drug
  • |
  • 0 Comments

2016 has been a tough year healthcare giant Johnson & Johnson (J&J). The company lost several multimillion dollar baby powder cancer trials, lost a $70 million Risperdal trial, and...

Read More
29
Dec, 2016
janssen

Janssen Pays Big In Doctor Payouts

  • By
  • Andrew Steinberg
  • |
  • Drug & Device Manufacturers
  • |
  • 0 Comments

The relationship between doctors and pharmaceutical companies has many restrictions. Pharmaceutical companies are not allowed to pay doctors kickbacks for prescribing certain medications. However, companies are allowed to pay...

Read More
16
Dec, 2016
risperdal lawsuit

Risperdal Case Tossed By Judge 11 Days Into Trial

  • By
  • Andrew Steinberg
  • |
  • Current Litigation & Lawsuit News,Dangerous Prescription Drug
  • |
  • 0 Comments

The sixth Risperdal case to go to trial in the Philadelphia mass tort program against manufacturers Janssen Pharmaceuticals and Johnson & Johnson (J&J) has come to an abrupt end...

Read More
14
Dec, 2016
risperdal trial

Sixth Risperdal Trial Underway In Philadelphia Court

  • By
  • Andrew Steinberg
  • |
  • Current Litigation & Lawsuit News,Dangerous Prescription Drug
  • |
  • 0 Comments

Just weeks after healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals reached a confidential settlement with a Risperdal plaintiff, the companies are going to trial in...

Read More
13
Dec, 2016
invokana

Invokana Lawsuits Coordinated Into MDL

  • By
  • Andrew Steinberg
  • |
  • Current Litigation & Lawsuit News,Dangerous Prescription Drug
  • |
  • 0 Comments

The U.S. Judicial Panel on Multidistrict Litigation granted a coordinated docket for more than 100 lawsuits alleging the diabetes drug Invokana caused significant injuries. Cases are currently being transferred...

Read More
07
Dec, 2016
risperdal verdict

What’s Next For Risperdal?

  • By
  • Andrew Steinberg
  • |
  • Current Litigation & Lawsuit News,Dangerous Prescription Drug
  • |
  • 0 Comments

Since healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals settled a Risperdal case in October, other plaintiffs in the Risperdal litigation hoped the settlement would set...

Read More
15
Nov, 2016
invokana lawsuit

Invokana Lawsuit Will Stay In Philadelphia Court

  • By
  • Andrew Steinberg
  • |
  • Current Litigation & Lawsuit News,Dangerous Prescription Drug
  • |
  • 0 Comments

Janssen Pharmaceuticals and its parent company, Johnson & Johnson (J&J), have been fighting several dozen lawsuits concerning their diabetes medication Invokana. One lawsuit includes a Texas man who suffered...

Read More
07
Nov, 2016
Cook IVC Filter

Philadelphia Xarelto Mass Tort Program Determines Bellwether Selection Process

  • By
  • Andrew Steinberg
  • |
  • Current Litigation & Lawsuit News,Dangerous Prescription Drug
  • |
  • 0 Comments

While more than 7,000 Xarelto lawsuits have been consolidated in a multidistrict litigation (MDL) to the Eastern District of Louisiana, there are nearly 1,000 cases pending in a Philadelphia...

Read More

Posts navigation

Older posts

Quick Links

  • About Us
  • Dangerous Drugs
  • Defective Medical Devices
  • News
  • Contact Us
  • Privacy Policy

Contact us

Address
3200 Travis Street
Third Floor
Houston, Texas 77006
Telephone: 888-529-4688
E-mail: info@baddrug.news
Follow us

Find Out More

Learn More - Footer

"*" indicates required fields

This field is for validation purposes and should be left unchanged.


©Copyright 2015 Consumer Advocacy News - All rights reserved